Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | EEF2K | O00418 | 1/20 | 0.43 |
| ▸ | PLK1 | P53350 | 1/20 | 0.43 |
| ▸ | PLK2 | Q9NYY3 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | ATM | Q13315 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | MPI | P34949 | 1/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49783 | 0.87 | MAPT (0.50) | MAPTKMT2ALMNAHTTALDH1A1 | |
| SCHEMBL30770580 | 0.79 | STAT3 (0.41) | LMNAEEF2KPLK1PLK2ATM | |
| SCHEMBL30770698 | 0.78 | STAT3 (0.39) | EEF2KPLK1PLK2STAT3 | |
| SCHEMBL11277727 | 0.78 | MEN1 (0.49) | MAPTKMT2ALMNAEEF2KPLK1 | |
| SCHEMBL11247339 | 0.78 | STAT3 (0.39) | MAPTKMT2AEEF2KPLK1PLK2 | |
| P-Xyloquinone SCHEMBL49964 | 0.78 | PLK1 (0.60) | MAPTKMT2ALMNAEEF2KPLK1 | |
| SCHEMBL10446296 | 0.76 | EEF2K (0.41) | MAPTKMT2ALMNAEEF2KPLK1 | |
| SCHEMBL11488266 | 0.74 | MAPT (0.34) | MAPTKMT2ALMNAHTTALDH1A1 | |
| SCHEMBL8615948 | 0.73 | MAPT (0.42) | MAPTKMT2ALMNAHTTALDH1A1 | |
| SCHEMBL13804759 | 0.73 | MAPT (0.42) | MAPTKMT2ALMNAHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250092312-A1 | ANTIPOLYMERANT COMPOSITIONS WITH BENZOQUINONE OR NAPHTHOQUINONE AND OXYGENATED AMINOPHENOL AND METHODS OF USING | ECOLAB USA INC. | 2025-03-20 | — | — | US | disclosed |
| WO-2025059441-A1 | ANTIPOLYMERANT COMPOSITIONS WITH BENZOQUINONE OR NAPHTHOQUINONE AND OXYGENATED AMINOPHENOL AND METHODS OF USING | ECOLAB USA INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| US-20230348501-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2023-11-02 | — | — | US | disclosed |
| US-11767334-B2 | Heteroaryl inhibitors of PDE4 | Tetra Discovery Partners, LLC (US) | 2023-09-26 | — | — | US | disclosed |
| CN-110997608-B | Dihydroxybiphenyl compound, bisphosphite compound, catalyst, method for producing aldehydes, and method for producing alcohols | 三菱化学株式会社 | 2023-07-25 | — | — | CN | disclosed |
| EP-3674282-B1 | BISPHOSPHITE COMPOUND, CATALYST, PRODUCTION METHOD OF ALDEHYDES, AND PRODUCTION METHOD OF ALCOHOL | MITSUBISHI CHEM CORP (JP) | 2021-09-22 | — | — | EP | disclosed |
| US-10793497-B2 | Dihydroxybiphenyl compound, bisphosphite compound, catalyst, production method of aldehydes, and production method of alcohol | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-10-06 | — | — | US | disclosed |
| EP-3674282-A1 | DIHYDROXYBIPHENYL COMPOUND, BISPHOSPHITE COMPOUND, CATALYST, METHOD FOR PRODUCING ALDEHYDES, AND METHOD FOR PRODUCING ALCOHOL | Mitsubishi Chemical Corporation (JP) | 2020-07-01 | — | — | EP | disclosed |
| US-20200181048-A1 | DIHYDROXYBIPHENYL COMPOUND, BISPHOSPHITE COMPOUND, CATALYST, PRODUCTION METHOD OF ALDEHYDES, AND PRODUCTION METHOD OF ALCOHOL | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-06-11 | — | — | US | disclosed |
| CN-110997608-A | Dihydroxybiphenyl compound, bisphosphite compound, catalyst, method for producing aldehyde, and method for producing alcohol | 三菱化学株式会社 | 2020-04-10 | — | — | CN | disclosed |
| US-9777024-B2 | Heteroaryl inhibitors of PDE4 | Tetra Discovery Partners, LLC (US) | 2017-10-03 | — | — | US | disclosed |
| US-20160137672-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2016-05-19 | — | — | US | disclosed |
| US-9221843-B2 | Heteroaryl inhibitors of PDE4 | Tetra Discovery Partners, LLC (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150119362-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2015-04-30 | — | — | US | disclosed |
| WO-2011126544-A2 | THYMOQUINONE ANALOGS FOR THE TREATMENT OF PANCREATIC CANCER | WAYNE STATE UNIVERSITY (US) | 2011-10-13 | — | — | WO | disclosed |
| US-20100129723-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-1933404-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | Mitsubishi Chemical Corporation (JP) | 2008-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181048-A1 | DIHYDROXYBIPHENYL COMPOUND, BISPHOSPHITE COMPOUND, CATALYST, PRODUCTION METHOD OF ALDEHYDES, AND PRODUCTION METHOD OF ALCOHOL | ADH1A, ADH1C, DERA | MAPT 4095/4885KMT2A 3591/4885LMNA 4740/4885 |
| US-10793497-B2 | Dihydroxybiphenyl compound, bisphosphite compound, catalyst, production method of aldehydes, and production method of alcohol | ADH1A, ADH1C, DERA | MAPT 4095/4885KMT2A 3591/4885LMNA 4740/4885 |
| US-20150119362-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | MAPT 4329/4885KMT2A 2665/4885LMNA 2756/4885 |
| US-20230348501-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | MAPT 4241/4885KMT2A 3408/4885LMNA 3544/4885 |
| US-11767334-B2 | Heteroaryl inhibitors of PDE4 | PDE4A, PDE4B, PDE4C | MAPT 4241/4885KMT2A 3408/4885LMNA 3544/4885 |
| US-20160137672-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | MAPT 4329/4885KMT2A 2665/4885LMNA 2756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.